CA9 and neoplasm: We found that CD133-expressing stem-cells had significantly higher mRNA expression levels of BECN1, BNIP3L, MAPLC3B, CAIX and HIF1A than CD133-negative tumor cells (p < 0.05) (Figure 2F).